Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of SILK will decline by -0.02% over the next 2 Weeks and hit $27.48 by Thursday, October 10, 2024. In that time frame, SILK's share price is expected to range between $24.79 and $29.80.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Oct 10, 2024 | 24.82 | 27.49 | 30.16 |
| Oct 9, 2024 | 25.26 | 27.49 | 29.73 |
| Oct 8, 2024 | 25.58 | 27.48 | 29.34 |
| Oct 7, 2024 | 25.91 | 27.49 | 29.05 |
| Oct 4, 2024 | 26.25 | 27.48 | 28.71 |
| Oct 3, 2024 | 26.59 | 27.49 | 28.43 |
| Oct 2, 2024 | 26.86 | 27.49 | 28.16 |
| Oct 1, 2024 | 27.09 | 27.49 | 27.89 |
| Sep 30, 2024 | 27.29 | 27.49 | 27.70 |
| Sep 27, 2024 | 27.42 | 27.48 | 27.55 |
SILK shares fell -0.04% in Monday, September 16, 2024's trading session, dropping from a previous close of $27.50 to move at $27.49. The stock demonstrated notable intraday movement (see SILK's key stats for a full breakdown), fluctuating between $27.49 and $27.50, a +0.04% trading range. While recent weeks have seen some volatility, SILK has managed to secure a -0.04% drop over the past 2 weeks. The downward price movement was accompanied by remained steady trading volume, with approximately 0 shares changing hands, 0 fewer than the previous session. This amounted to $0.00 in total market activity.
Will SILK Continue Its Upward Trend?
According to analyst ratings and projections for SILK, Silk Road Medical, Inc shares are anticipated to increase by +8.86%, potentially reaching $30.16 per share by October 10, 2024. Short-term technical indicators currently suggest a neutral sentiment for SILK. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 11 positive trading days within the past 30 sessions. Based on the SILK stock forecast, now is a good time to buy SILK stock because its current trading price is +0.01% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on SILK covering social and institutional perspectives.
SILK Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into SILK's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 68.97% to 77.87%) indicate the stock is leaning toward a strong bullish momentum phase. The 50-day RSI, at 63.43%, suggests strong medium-term momentum. However, the 100-day RSI, at 56.81%, maintains a neutral outlook for the long term. Insights into SILK's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Silk Road Medical, Inc Monthly Forecast 2024–2025
September 2024
According to our latest forecast models, Silk Road Medical, Inc (SILK) is positioned to show a strong performance in September 2024. The price is predicted to move between $12.29 and $20.65, settling at an average of $16.33. This could translate to a -40.60% loss.
October 2024
Based on current market signals, Silk Road Medical, Inc is projected to trend october 2024. We forecast a trading range from $5.94 to $20.19, with a likely average price of $13.38. Investors could expect a potential return of -51.33%.
November 2024
Our predictive algorithms indicate Silk Road Medical, Inc stock may see a shift in November 2024. The expected range spans $6.04–$22.10, with an average target of $12.10. This represents a cautious outlook and a possible loss of -55.98%.
December 2024
Analyzing established trends, Silk Road Medical, Inc looks set to move in December 2024. Projections place the stock between $8.03 and $18.75, averaging around $13.76. This suggests a -49.95% loss from current levels.
January 2025
Market indicators suggest Silk Road Medical, Inc could experience notable changes during January 2025. Prices could fluctuate within $7.47 to $17.44, with a midpoint forecast of $12.40. The stock might deliver a -54.89% loss.
February 2025
Forecasting for February 2025, models estimate that Silk Road Medical, Inc may undergo key fluctuations. If trends hold, the stock might trade between $7.00 and $17.94, averaging $12.92. This signals a cautious trajectory with potential returns around -53.00%.
March 2025
According to our latest forecast models, Silk Road Medical, Inc (SILK) is positioned to show a strong performance in March 2025. The price is predicted to move between $1.31 and $14.76, settling at an average of $8.38. This could translate to a -69.52% loss.
April 2025
Based on current market signals, Silk Road Medical, Inc is projected to trend april 2025. We forecast a trading range from $1.53 to $12.63, with a likely average price of $6.96. Investors could expect a potential return of -74.68%.
May 2025
Our predictive algorithms indicate Silk Road Medical, Inc stock may see a shift in May 2025. The expected range spans $4.01–$14.35, with an average target of $9.01. This represents a cautious outlook and a possible loss of -67.22%.
June 2025
Analyzing established trends, Silk Road Medical, Inc looks set to move in June 2025. Projections place the stock between $2.87 and $12.35, averaging around $7.50. This suggests a -72.72% loss from current levels.
July 2025
Market indicators suggest Silk Road Medical, Inc could experience notable changes during July 2025. Prices could fluctuate within $2.09 to $13.98, with a midpoint forecast of $8.01. The stock might deliver a -70.86% loss.
August 2025
Forecasting for August 2025, models estimate that Silk Road Medical, Inc may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $8.95, averaging $3.10. This signals a cautious trajectory with potential returns around -88.72%.
September 2025
According to our latest forecast models, Silk Road Medical, Inc (SILK) is positioned to show a strong performance in September 2025. The price is predicted to move between $0.00 and $7.14, settling at an average of $2.29. This could translate to a -91.67% loss.
SILK's history of dividends and stock splits also plays a role in long-term investor confidence.

